Gryphon Investors Sells RoC Skincare to Bridgepoint, Signaling Global Expansion

Gryphon Investors, a prominent middle market private equity firm, has successfully completed the sale of RoC Skincare to Bridgepoint Europe VII, a fund dedicated to investing in mid-market growth businesses. This strategic move marks a significant milestone in RoC Skincare's journey towards global expansion and product diversification. Founded in Paris in 1957 by Dr. Jean-Charles Lissarrague, RoC Skincare has established itself as a leader in providing innovative solutions for ageing skin, boasting a global presence including in the US, Canada, Europe, Australia, and China.

Strategic Growth and Expansion

Since Gryphon's initial investment in 2019, RoC Skincare has seen remarkable organic growth, expanded its distribution network both in the US and internationally, and enriched its product portfolio. This growth trajectory has been bolstered by strategic advisory services from Raymond James for M&A, Kirkland & Ellis for legal matters, and PWC for financial and tax due diligence. The acquisition by Bridgepoint Europe VII promises to propel RoC Skincare into its next phase of growth, focusing on further market penetration and innovation in skincare solutions.

Advisory Excellence and Strategic Partnerships

The transaction was facilitated by CG Sawaya Partners (operating under Canaccord Genuity), which also originally advised on the sale of RoC Skincare from Johnson & Johnson Consumer. This partnership underscores the importance of strategic advisory in navigating the complexities of M&A transactions, ensuring a smooth transition for RoC Skincare into the Bridgepoint portfolio. The collaboration between Gryphon Investors and these advisory firms has laid a solid foundation for RoC Skincare's future endeavors under Bridgepoint's ownership.

A New Chapter for RoC Skincare

The sale of RoC Skincare to Bridgepoint Europe VII heralds a new chapter for the skincare brand, promising an infusion of resources and expertise to fuel its continued growth and innovation. As RoC Skincare embarks on this exciting journey, its commitment to delivering dermatologist-backed skin health solutions remains unwavering. The brand's legacy, coupled with Bridgepoint's strategic focus on mid-market growth businesses, sets the stage for accelerated expansion and product development in the skincare industry.

The transaction between Gryphon Investors and Bridgepoint not only signifies a pivotal moment for RoC Skincare but also highlights the dynamic nature of the skincare market. With an ever-increasing demand for innovative and effective skincare solutions, RoC Skincare's evolution under new ownership is poised to meet and exceed consumer expectations, driving the brand towards new heights of success.